About Molecule.one
Molecule.one is a company based in Warsaw (Poland) founded in 2016 by Pawel Wodarczyk Pruszynski, Piotr Byrski, and Pawel Laskarzewski.. Molecule.one has raised $4.63 million across 2 funding rounds from investors including Atmos Ventures, AME Cloud Ventures and Cherubic Ventures. Molecule.one offers products and services including Custom Synthesis, SpaceM1, M1 RetroScore, Data Generation & Licensing, and MariaAI. Molecule.one operates in a competitive market with competitors including Insitro, Certara, HotSpot Therapeutics, CytoReason and GRO Biosciences, among others.
- Headquarter Warsaw, Poland
- Founders Pawel Wodarczyk Pruszynski, Piotr Byrski, Pawel Laskarzewski
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Molecule One Sp. Z O.O.
-
Annual Revenue
$239.18 K (USD)212as on Dec 31, 2022
-
Net Profit
$-1.31 M (USD)-122as on Dec 31, 2022
-
EBITDA
$-1.23 M (USD)-123as on Dec 31, 2022
-
Total Equity Funding
$4.63 M (USD)
in 2 rounds
-
Latest Funding Round
$4.63 M (USD), Seed
May 04, 2021
-
Investors
Atmos Ventures
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecule.one
Molecule.one offers a comprehensive portfolio of products and services, including Custom Synthesis, SpaceM1, M1 RetroScore, Data Generation & Licensing, and MariaAI. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Reliable service for synthesizing compounds tailored to client needs.
Platform for accessing over 1 trillion drug-like molecules for synthesis.
AI tool to predict synthetic accessibility of novel molecules.
Custom dataset creation for chemistry problem-solving.
Internal agent for automating molecular synthesis processes.
Unlock access to complete
Funding Insights of Molecule.one
Molecule.one has successfully raised a total of $4.63M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $4.63 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $4.6M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2021 | Amount | Seed - Molecule.one | Valuation | Atmos Ventures | |
| Aug, 2019 | Amount | Seed - Molecule.one | Valuation | Sunfish Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Molecule.one
Molecule.one has secured backing from 8 investors, including venture fund and angel investors. Prominent investors backing the company include Atmos Ventures, AME Cloud Ventures and Cherubic Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
AME Cloud Ventures is focused on investing in data-driven technology companies.
|
Founded Year | Domain | Location | |
|
Seed-stage technology startups are invested in by Cherubic Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Molecule.one
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Molecule.one
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Molecule.One Comparisons
Competitors of Molecule.one
Molecule.one operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, Certara, HotSpot Therapeutics, CytoReason and GRO Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Provider of a platform for in silico drug discovery and consulting services
|
|
| domain | founded_year | HQ Location |
Developer of a platform for protein function analysis
|
|
| domain | founded_year | HQ Location |
Immune system-based drugs are discovered via biological data analytics.
|
|
| domain | founded_year | HQ Location |
Synthetic biology tools are developed via genetic code recoding techniques.
|
|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for materials informatics
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Molecule.One
Frequently Asked Questions about Molecule.one
When was Molecule.one founded?
Molecule.one was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is Molecule.one located?
Molecule.one is headquartered in Warsaw, Poland.
Who is the current CEO of Molecule.one?
Piotr Byrski is the current CEO of Molecule.one. They have also founded this company.
Is Molecule.one a funded company?
Molecule.one is a funded company, having raised a total of $4.63M across 2 funding rounds to date.
What is the annual revenue of Molecule.one?
Annual revenue of Molecule.one is $239.18K as on Dec 31, 2022.
What does Molecule.one do?
Founded in 2016 and based in Warsaw, Poland, Molecule.one operates in the biotechnology sector. AI-driven software is developed to assist in molecule drug designing and synthesis. Search criteria are selected by users, after which relevant reactions are proposed, scored for viability, and assembled into complete synthesis pathways. This technology supports research and development processes in pharmaceutical applications.
Who are the top competitors of Molecule.one?
Molecule.one's top competitors include Insitro, HotSpot Therapeutics and Certara.
What products or services does Molecule.one offer?
Molecule.one offers Custom Synthesis, SpaceM1, M1 RetroScore, Data Generation & Licensing, and MariaAI.
Who are Molecule.one's investors?
Molecule.one has 8 investors. Key investors include Atmos Ventures, AME Cloud Ventures, Cherubic Ventures, Possible Ventures, and Firlej Kastory.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.